Finance

Beta
Lists
Q4 2026 earnings
See results
BALAXI:NSE
Balaxi Pharmaceuticals Ltd
₹ २६.००
-०.०४%
(-०.०१०) 1D
जुन २, १०:१८:०४ GMT+५:३०  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BALAXI...
Open
₹ २५.९६
High
₹ २६.०१
Low
₹ २५.३१
Mkt. cap
१.४४ अरब
Avg. vol.
४०.०५ हजार
Volume
६.२५ हजार
P/E ratio
१५.१९
52-wk high
₹ ६३.९०
52-wk low
₹ १५.२०
EPS
₹ १.७१
No. of employees
६००
Open
₹ २५.९६
High
₹ २६.०१
Low
₹ २५.३१
Mkt. cap
१.४४ अरब
Avg. vol.
४०.०५ हजार
Volume
६.२५ हजार
P/E ratio
१५.१९
52-wk high
₹ ६३.९०
52-wk low
₹ १५.२०
EPS
₹ १.७१
No. of employees
६००
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
३० मिनेट पहिले
Fifth Third Shifts To NYSE As Capital Structure And Valuation Draw Focus
Seeking Alpha
Seeking Alpha
·
२९ मिनेट पहिले
My Oh My, What A Month Of May (null:SPX)
Investor's Business Daily
Investor's Business Daily
·
३ घण्टा पहिले
Dow Jones Futures: Broadcom, Micron, Nvidia, Sandisk Rally; Credo Plunges
About Balaxi Pharmaceuticals Ltd
CEO-
Employees६००
Founded१९४२
Headquarters-
Sector-
Last report
२०२६ मे २८
Fiscal period
Q4 2026
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
७३.६३ करोड / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
७०.७४ करोड
५६.१८ करोड
७२.५४ करोड
७३.६३ करोड
Cost of goods sold
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
४०.५५ करोड
Cost of revenue
३९.५६ करोड
२९.०३ करोड
४१.७४ करोड
४०.५५ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.०३ करोड
२५.९८ करोड
२७.७२ करोड
३०.०४ करोड
Operating expense
२७.५० करोड
२६.४६ करोड
२८.२८ करोड
३०.६९ करोड
Total operating expenses
६७.०६ करोड
५५.४९ करोड
७०.०१ करोड
७१.२४ करोड
Operating income
३.६९ करोड
६८.४१ लाख
२.५३ करोड
२.३९ करोड
Other non operating income
-१.७८ करोड
१.५८ करोड
९.५७ लाख
-१.०० हजार
EBT including unusual items
९०.३४ लाख
१.३८ करोड
१.६१ करोड
१.४० करोड
EBT excluding unusual items
९०.३४ लाख
१.३८ करोड
१.६१ करोड
१.४० करोड
Income tax expense
६१.३३ लाख
१.१७ करोड
१.३० करोड
७८.९७ लाख
Effective tax rate
६७.८९%
८४.८२%
८१.०५%
५६.३१%
Other operating expenses
-
-
-
-
Net income
२९.०१ लाख
२०.९० लाख
३०.५० लाख
६१.२८ लाख
Net profit margin
०.४१%
०.३७%
०.४२%
०.८३%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
Net interest expenses
-१.०१ करोड
-८९.२२ लाख
-१.०२ करोड
-९८.९९ लाख
Depreciation and amortization charges
४६.२५ लाख
४८.४५ लाख
५५.९५ लाख
६४.६५ लाख
EBITDA
४.११ करोड
१.१६ करोड
२.९६ करोड
२.८२ करोड
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more